Avalo Therapeutics was originally founded and incorporated under the corporate name Cerecor Inc. before undergoing a strategic corporate rebranding. The biopharmaceutical enterprise was established by life science entrepreneurs and scientific founders aiming to develop advanced treatments for pediatric and adult conditions, subsequently shifting its core strategic focus entirely toward immunology and targeted therapies addressing immune dysregulation.